A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells

Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein

(2014) P. Boutet et al.   JOURNAL OF IMMUNOLOGY

Regulation of Ligands for the NKG2D Activating Receptor

(2013) David H. Raulet et al.   Annual Review of Immunology

Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17

(2013) Guranda Chitadze et al.   INTERNATIONAL JOURNAL OF CANCER

Conditional probability of long-term survival in glioblastoma

(2012) Derek R. Johnson et al.   CANCER

A-Disintegrin and Metalloprotease (ADAM) 10 and 17 promote self-renewal of brain tumor sphere forming cells

(2012) Harry Bulstrode et al.   CANCER LETTERS

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells

(2012) Fabian Wolpert et al.   JOURNAL OF NEUROIMMUNOLOGY

Human NKG2D-ligands: cell biology strategies to ensure immune recognition

(2012) Lola Fernández-Messina et al.   Frontiers in Immunology

Glioblastoma stem cells

(2011) Ghazaleh Tabatabai et al.   CELL AND TISSUE RESEARCH

ADAM17 promotes glioma cell malignant phenotype

(2011) Xuguang Zheng et al.   MOLECULAR CARCINOGENESIS

Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy

(2011) Henry Ogbomo et al.   TRENDS IN MOLECULAR MEDICINE

Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes

(2010) O. Ashiru et al.   CANCER RESEARCH

Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

(2010) J. Wei et al.   CLINICAL CANCER RESEARCH

Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

(2010) T. Di Tomaso et al.   CLINICAL CANCER RESEARCH

Activating and inhibitory receptors of natural killer cells

(2010) Hollie J Pegram et al.   IMMUNOLOGY AND CELL BIOLOGY

Transforming Growth Factor- 1-Mediated Activation of NF- B Contributes to Enhanced ADAM-12 Expression in Mammary Carcinoma Cells

(2010) A. Ray et al.   MOLECULAR CANCER RESEARCH

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

(2010) J. Wei et al.   MOLECULAR CANCER THERAPEUTICS

NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties

(2009) R. Castriconi et al.   JOURNAL OF IMMUNOLOGY

ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C-  Dependent and Promotes Glioblastoma Cell Migration

(2009) Z. A. Kohutek et al.   JOURNAL OF NEUROSCIENCE

Biology of glioma cancer stem cells

(2009) Deric M. Park et al.   MOLECULES AND CELLS

Toward effective immunotherapy for the treatment of malignant brain tumors

(2009) Duane A. Mitchell et al.   Neurotherapeutics

Tumor-Associated MICA Is Shed by ADAM Proteases

(2008) I. Waldhauer et al.   CANCER RESEARCH